ESR1 and breast carcinoma: In addition, IL-6 was found to significantly induce the in vitro and in vivo growth of estrogen receptor (ER) positive breast cancer cells [15].The ability of IL-6 to promote breast cancer cell migration was also confirmed by our group [4].